Karen Cesarkas

5.7k total citations · 1 hit paper
11 papers, 4.1k citations indexed

About

Karen Cesarkas is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Karen Cesarkas has authored 11 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Karen Cesarkas's work include Clostridium difficile and Clostridium perfringens research (3 papers), Gut microbiota and health (3 papers) and RNA regulation and disease (2 papers). Karen Cesarkas is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (3 papers), Gut microbiota and health (3 papers) and RNA regulation and disease (2 papers). Karen Cesarkas collaborates with scholars based in Israel and United States. Karen Cesarkas's co-authors include Ninette Amariglio, Gideon Rechavi, Jasmine Jacob‐Hirsch, Sharon Moshitch-Moshkovitz, Martin Kupiec, Schraga Schwartz, Dan Dominissini, Mali Salmon‐Divon, Sivan Osenberg and Rotem Sorek and has published in prestigious journals such as Nature, Nature Communications and Scientific Reports.

In The Last Decade

Karen Cesarkas

11 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

2012 3.7k citations Dan Dominissini, Sharon Moshitch-Moshkovitz et al. Nature profile →

Peers

Countries citing papers authored by Karen Cesarkas

Since Specialization

Citations

This map shows the geographic impact of Karen Cesarkas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Cesarkas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Cesarkas more than expected).

Fields of papers citing papers by Karen Cesarkas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Cesarkas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Cesarkas. The network helps show where Karen Cesarkas may publish in the future.

Co-authorship network of co-authors of Karen Cesarkas

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Cesarkas. A scholar is included among the top collaborators of Karen Cesarkas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Cesarkas. Karen Cesarkas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis 2020 ·Breast Cancer Research ·Adi Zundelevich, Maya Dadiani, (unknown), (unknown), Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, (unknown), Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam	67
2	Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing 2018 ·Journal of Visualized Experiments ·Ayelet Di Segni, Tzipi Braun, (unknown), (unknown), Efrat G. Saar, Karen Cesarkas, James E. Squires, Nathan Keller, Yael Haberman	23
3	Whole-genome sequencing reveals principles of brain retrotransposition in neurodevelopmental disorders 2018 ·Cell Research ·Jasmine Jacob‐Hirsch, Eran Eyal, Binyamin A. Knisbacher, Jonathan Roth, Karen Cesarkas, Chen Dor, Sarit Farage-Barhom, Vered Kunik, Anthony Simon, Moran Gal, Michal Yalon, Sharon Moshitch-Moshkovitz, Rick Tearle, Shlomi Constantini, Erez Y. Levanon, Ninette Amariglio, Gideon Rechavi	51
4	Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing 2018 ·Journal of Visualized Experiments ·Ayelet Di Segni, Tzipi Braun, (unknown), (unknown), Efrat G. Saar, Karen Cesarkas, James E. Squires, Nathan Keller, Yael Haberman	1
5	RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure 2017 ·Nature Communications ·Oz Solomon, Ayelet Di Segni, Karen Cesarkas, Hagit T. Porath, Victoria Marcu‐Malina, Orel Mizrahi, Noam Stern‐Ginossar, Nitzan Kol, Sarit Farage-Barhom, (unknown), Yaniv Lerenthal, Erez Y. Levanon, Ninette Amariglio, Ron Unger, Itamar Goldstein, Eran Eyal, Gidi Rechavi	77
6	Fecal microbial characterization of hospitalized patients with suspected infectious diarrhea shows significant dysbiosis 2017 ·Scientific Reports ·Tzipi Braun, Ayelet Di Segni, (unknown), (unknown), James E. Squires, (unknown), Efrat G. Saar, Karen Cesarkas, Gill Smollan, Batia Weiss, Sharon Amit, Nathan Keller, Yael Haberman	27
7	Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR) 2013 ·RNA ·Oz Solomon, Shirley Oren, Michal Safran, (unknown), Pinchas Akiva, Jasmine Jacob‐Hirsch, Karen Cesarkas, (unknown), Ninette Amariglio, Ron Unger, Gideon Rechavi, Eran Eyal	101
8	Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq breakdown → 2012 ·Nature ·Dan Dominissini, Sharon Moshitch-Moshkovitz, Schraga Schwartz, Mali Salmon‐Divon, Lior Ungar, Sivan Osenberg, Karen Cesarkas, Jasmine Jacob‐Hirsch, Ninette Amariglio, Martin Kupiec, Rotem Sorek, Gideon Rechavi	3679
9	Detection of BCR‐ABL1 mutations in chronic myeloid leukaemia by massive parallel sequencing 2012 ·British Journal of Haematology ·Eran Eyal, (unknown), Amnon Amir, Karen Cesarkas, Jasmine Jacob‐Hirsch, (unknown), Arnon Nagler, Gideon Rechavi, Ninette Amariglio	4
10	MDR1 expression identifies human melanoma stem cells 2008 ·Biochemical and Biophysical Research Communications ·Gilmor I. Keshet, Itamar Goldstein, Orit Itzhaki, Karen Cesarkas, (unknown), Arkadi Yakirevitch, Avraham J. Treves, Jacob Schachter, Ninette Amariglio, Gideon Rechavi	87
11	Aym1, a mouse meiotic gene identified by virtue of its ability to activate early meiotic genes in the yeast Saccharomyces cerevisiae 2004 ·Developmental Biology ·Mira Malcov, Karen Cesarkas, (unknown), (unknown), (unknown), (unknown), Ronald S. Goldstein, Shira Sagee, Yona Kassir, Jeremy Don	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact